Details for New Drug Application (NDA): 050629
✉ Email this page to a colleague
The generic ingredient in DOXORUBICIN HYDROCHLORIDE is doxorubicin hydrochloride. There are seventeen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the doxorubicin hydrochloride profile page.
Summary for 050629
| Tradename: | DOXORUBICIN HYDROCHLORIDE |
| Applicant: | Pfizer |
| Ingredient: | doxorubicin hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 050629
| Mechanism of Action | Topoisomerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 050629
Suppliers and Packaging for NDA: 050629
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE;INJECTION | 050629 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-0255 | 0069-0255-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-0255-10) / 10 mL in 1 VIAL, SINGLE-DOSE |
| DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE;INJECTION | 050629 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-0277 | 0069-0277-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-0277-02) / 10 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2MG/ML | ||||
| Approval Date: | Dec 23, 1987 | TE: | AP | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/100ML | ||||
| Approval Date: | May 3, 1988 | TE: | AP | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 150MG/75ML | ||||
| Approval Date: | Mar 28, 2011 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
